Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma 1Hematologic Neoplasms 1Anemia 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × ferrous succinate × Clear all
NCT05784870 2023-08-25

A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

Zhongnan Hospital

Phase 3 Unknown
168 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03010579 2017-01-05

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Peking University

Phase 4 Unknown
70 enrolled
Classical hematologyLymphoid

Anemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡